Fighting Cancer
This is our Mission

"The most advanced applications for cancer diagnosis, based on rare cancer cell detection: Ikonisys will provide innovative, high quality medical diagnostic products that meet or exceed our customer's requirements, the expectations of the health-care community and the needs of the patients for whom our products are designed."

Short Company

Ikonisys is a leading cell-based diagnostics company that markets the proprietary Ikoniscope® Digital Microscope, engineered to provide highly accurate and reliable detection of rare cells. Leveraging advanced molecular and immunological markers, Ikoniscope-built applications are widely used across the US and Europe for diagnosing various cancers. Ikonisys has received FDA clearance for several automated diagnostic applications, which are also marketed in Europe under CE certification.

The Ikoniscope instrument operates through the proprietary Ikonisoft® software system. This highly optimized software manages the Ikoniscope’s robotic components, image acquisition, and cell detection, enabling true hands-off slide handling for continuous, year-round operation.

A suite of oncoFISH® diagnostic applications is built on the Ikonisoft engine, finely tuned for detecting cancer-related chromosomal abnormalities using FISH (Fluorescence In Situ Hybridization). These clinical diagnostic applications are utilized for diagnosing various types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH HER2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK), and a range of hematological cancers using the Explorer applications.

The exceptional ability of the Ikoniscope to detect rare cells is particularly effective in identifying circulating tumor cells (CTC), combining up to six immunofluorescent and FISH markers for comprehensive detection.

Our Vision
Mission and Values

Our vision is to revolutionize cancer diagnostics through advanced FISH (Fluorescence In Situ Hybridization) technology, delivering precise, reliable, and accessible solutions for early detection and personalized treatment.

We aim to empower healthcare providers and patients with innovative FISH-based tools that improve outcomes, enhance quality of life, and ultimately lead to a world where cancer is manageable and curable.
We are committed to pushing the boundaries of science and technology, continuously developing cutting-edge solutions that drive progress in cancer diagnostics and personalized medicine.
We uphold the highest standards of honesty, transparency, and ethical practices in all our research, product development, and interactions with stakeholders.
We believe in the power of teamwork and partnership, fostering a collaborative environment that brings together diverse expertise to achieve breakthroughs in cancer diagnostics and improve patient outcomes.

Ikonisys is founded in
New Haven,
Connecticut, USA

The beginning


FDA clearance.
Launch of the IKONISCOPE GEN1

The R&D times


Market development
30 Ikoniscope Microscopes sold

Market Penetration


New Research and Development
New oncoFISH ALK application.
New release of oncoFISH HER2

Application development



We are growing

Credibly innovate granular internal or "organic" sources whereas high standards in web-readiness. Energistically scale future-proof core competencies vis-a-vis impactful experiences.
Mario Crovetto

CEOMario Crovetto

Michael Kilpatrick

CSOMichael Kilpatrick

Alessandro Mauri

CFOAlessandro Mauri

Alessandro Nosei

CDOAlessandro Nosei

Vittorio Grazioli

R&DVittorio Grazioli

Board of Directors and

Our board of directors comprises seasoned industry leaders and experts, dedicated to steering our company towards innovation, strategic growth, and excellence in the medical device industry
Francesco Trisolini

COOFrancesco Trisolini

ScientistEric Kershnar

BOARD OF DIRECTORS:Vittorio Grazioli, Chairman

Mario Mauri, Director
Roberto Rettani, Director
Alberto Calvo, Director

Our Prestigious
Scientific Partnerships

Hub Innovazione Trentino (HIT)
innovation hub located in Trentino, Italy, focusing on fostering collaboration and innovation in various fields.
Bruno Kessler Foundation
a research organization specializing in scientific research and technology transfer in the fields of information technology, materials science, and environmental sciences.
Department of Industrial Engineering, UniTrento
An academic department dedicated to research and education in industrial engineering, emphasizing innovation in industrial processes and systems.
A research initiative that evaluates and maximizes the societal and technological impact of scientific and industrial projects.
UConn Health
The healthcare division of the University of Connecticut, encompassing a medical school, dental school, and hospital dedicated to patient care, education, and research.
European Association for Predictive, Preventive & Personalised Medicine
An organization advocating for healthcare strategies that focus on prediction, prevention, and personalized treatments to improve patient outcomes.
A laboratory specializing in medical diagnostics and the development of innovative health technologies.
Oncology Department, University Campus Bio-Medico, Rome
A department committed to advancing cancer research, treatment, and education through clinical and translational studies.


Innovation at the Core

In the medical device industry, continuous R&D is the cornerstone of innovation, driving the development of cutting-edge technologies that improve patient outcomes and healthcare efficiency

Patient-Centric InnovationR&D
Next innovations

Our R&D strategy is patient-centric, focusing on developing medical devices that not only meet regulatory standards but also significantly enhance the quality of life for patients
Our platform of AI for cell detection at its 2nd generations
Direct line of FISH probes production
Urine CTCs
The frontier of the cancer diagnostics


Helping your Laboratory to grow

Our solutions are world class cancer diagnostic solutions for advanced Laboratories.

By integrating our advanced devices into your laboratories, you will experience significant growth through enhanced efficiency, increased accuracy, and cutting-edge technological capabilities, positioning your facility at the forefront of scientific innovation and excellence

Get in touch

Come and visit our quarters or simply send us an email anytime you want. We are open to all requests.
5 Science Park, New Haven, Connecticut
06511 - USA
Call us


Ikonisys Inc.


Ikonisys, Inc.
5 Science Park, New Haven, Connecticut 06511, USA
Phone: +1.203.776.0791


Ikonisys, SA
62, rue de Caumartin
75009 Paris


Ikonisys S.r.l.
Via dell’Ambrosiana,22
20123 Milano

Copyright by Ikonisys Inc. All rights reserved.